Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Why price level matters is that it frames where supply and demand meet, shaping momentum and risk. Use this context to make smarter choices.
28,103 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Peloton shares surged on Tuesday after two investor-focused announcements sparked a burst of buying interest. This gu...
BNB slips on a brief pullback, but longer-term momentum remains constructive as rising moving averages and a quiet re...
Geopolitics just accelerated volatility in energy markets. The rejection of a ceasefire proposal by iran has traders ...
A street vendor’s duck strolled into a presidential briefing in Mexico City, becoming an instant social-media sensati...
spacex tokenized stock bets surged as crypto leverage spilled into equities, with more than $50 million in 48-hour li...
Investors often chase eye-popping targets, but can Nvidia stock truly double in 12 months? This article breaks down t...
El Salvador’s bitcoin reserve faces renewed IMF scrutiny as market swings test a government crypto policy, raising ac...
When a billionaire investor voices concern about Bitcoin, questions follow. This article digs into what the claim mig...
A Michigan case alleges a dentist billed Medicaid for work not performed. This article explains what happened, how Me...
Political wrangling and funding gaps create a tightening knot for Social Security. This article explains the math, th...
Anthropic, the Claude-maker, confidentially files to go public, igniting talk of a potential trillion-dollar valuatio...